Back
Curaleaf Holdings Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
31
CURLF
Curaleaf Holdings
Last Price:
3.11
Seasonality Move:
21.38%
Sell
45
NBY
NovaBay Pharmaceuticals
Last Price:
0.78
Seasonality Move:
-8.12%
Sell
31
Curaleaf Holdings (CURLF)
is a Sell
Is Curaleaf Holdings a Buy, Sell or Hold?
- The current Curaleaf Holdings [CURLF] share price is $2.96. The Score for CURLF is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- CURLF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.75. The Score for NBY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CURLF Stock Price Chart
What is Curaleaf Holdings's stock price today?
-
The Curaleaf Holdings share price today is $2.96
The current trend is relatively stagnant and CURLF is experiencing slight buying pressure.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.75
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBY is experiencing buying pressure, which is a positive indicator for future bullish movement.
CURLF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 44.71 | Sell |
| Chaikin Money Flow: | 60957 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.89 - 3.25) | Sell |
| Bollinger Bands (100): | (2.92 - 3.94) | Sell |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 62.6 | Buy |
| Chaikin Money Flow: | 101564 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.59 - 0.71) | Buy |
| Bollinger Bands (100): | (0.31 - 1.87) | Sell |
CURLF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.15 | Sell |
| 20-day SMA: | 3.09 | Sell |
| 50-day SMA: | 3.01 | Sell |
| 200-day SMA: | 4.24 | Sell |
| 8-day EMA: | 3.06 | Sell |
| 20-day EMA: | 3.09 | Sell |
| 50-day EMA: | 3.16 | Sell |
| 200-day EMA: | 3.79 | Sell |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.64 | Buy |
| 20-day SMA: | 0.64 | Buy |
| 50-day SMA: | 0.59 | Buy |
| 200-day SMA: | 2.68 | Sell |
| 8-day EMA: | 0.67 | Buy |
| 20-day EMA: | 0.65 | Buy |
| 50-day EMA: | 0.74 | Buy |
| 200-day EMA: | 6.35 | Sell |
Curaleaf Holdings Earnings Growth & CURLF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.09 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Curaleaf Holdings Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||